3011-19: Mini Concurrent Sessions: Pharmacology

5 (1 vote)

3011-19: Using Genetic Testing to assist with Treatment Decisions in the Outpatient Psychiatric Setting: Case Studies from the Clinic  |  Preventing the Ills of Too Many Pills: Using Collaborative Deprescribing

Mini concurrent sessions are presented live as two 20-minute presentations plus Q&A. Below they are offered as individual audio recordings.

Using Genetic Testing to assist with Treatment Decisions in the Outpatient Psychiatric Setting: Case Studies from the Clinic
Genetic testing is now being used to guide treatment decisions for appropriate psychotropic medication prescribing, as well as identifying patients who have moderately and significantly reduced folic acid conversion. The selected case studies will discuss how treatment decisions were affected and how the genetic guided treatment affected patient outcomes.
Presenters:  Evelyn J. Norton, APN, DNP, PMHNP-BC; Claire E. Oliver, MSN, PMHNP-BC; Kristin E. Katsenes, RN, BSN, PEL-CSN (IL) 

Preventing the Ills of Too Many Pills: Using Collaborative Deprescribing
This presentation introduces dynamic processes of the therapeutic provider-patient relationship in psychopharmacologic management of symptoms, and case examples of common situations involving polypharmacy. A collaborative deprescribing framework will be delineated including: rational prescribing and deprescribing principles, risk-benefit analysis guidelines, and best practice in integration of patient preferences and values.
Presenter:  Joanne DeSanto Iennaco, PhD 

Disclosures:  The presenters and planners have no conflict of interest or commercial support to disclose.  Off-label use of medications will not be discussed during this presentation.


Session Length:  34 minutes

Target Audience:  RN, APRN


Learning Outcomes:
Upon completion of this presentation, the participant will be able to:

  1. Apply the results of genetic testing in their treatment decisions to positively affect patient outcomes.
  2. Describe principles of deprescribing in psychiatry, including risk-benefit analysis and integration of patient reference.

Keywords:  Deprescribing, Psychopharmacology, Collaborative Deprescribing, Pharmacodynamics, Pharmacokinetics

Nursing Continuing Professional Development:
0.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.


Originally Presented
APNA 33rd Annual Conference
New Orleans, Louisiana

The contact hours for this session expire:  November 30, 2021

Components visible upon registration.